CytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer
Go back to CytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer| Eaton Vance Dividend Builder Fd Cl C (NASDAQ: CTMX) | Delayed: 3.37 +0.02 (0.60%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.35 | 52 Week High | $24.68 | |||
| Open | $3.34 | 52 Week Low | $9.10 | |||
| Day High | $3.38 | P/E | N/A | |||
| Day Low | $3.28 | EPS | $0.00 | |||
| Volume | 797,051 | |||||
